
Ly D. Pham
Examiner (ID: 13044, Phone: (571)272-1793 , Office: P/2827 )
| Most Active Art Unit | 2827 |
| Art Unit(s) | 2713, 2827, 2818 |
| Total Applications | 2188 |
| Issued Applications | 2041 |
| Pending Applications | 77 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20202501
[patent_doc_number] => 12405279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Method for preparing a sample
[patent_app_type] => utility
[patent_app_number] => 17/710329
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710329 | Method for preparing a sample | Mar 30, 2022 | Issued |
Array
(
[id] => 17750849
[patent_doc_number] => 20220229054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMBINATION OF REVERSIBLE AND IRREVERSIBLE CELL LABELING FOR ANALIZING RECEPTOR-LIGAND KOFF RATE
[patent_app_type] => utility
[patent_app_number] => 17/707726
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707726 | COMBINATION OF REVERSIBLE AND IRREVERSIBLE CELL LABELING FOR ANALIZING RECEPTOR-LIGAND KOFF RATE | Mar 28, 2022 | Abandoned |
Array
(
[id] => 19609552
[patent_doc_number] => 12158424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Methods of measuring exosomes using intrinsic fluorescence
[patent_app_type] => utility
[patent_app_number] => 17/706281
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 24
[patent_no_of_words] => 8938
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17706281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/706281 | Methods of measuring exosomes using intrinsic fluorescence | Mar 27, 2022 | Issued |
Array
(
[id] => 17898391
[patent_doc_number] => 20220308053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Method and reagents for the detection of an autoantibody
[patent_app_type] => utility
[patent_app_number] => 17/656563
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656563 | Method and reagents for the detection of an autoantibody | Mar 24, 2022 | Issued |
Array
(
[id] => 20159304
[patent_doc_number] => 12385925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Anti-VLA-4 related assays
[patent_app_type] => utility
[patent_app_number] => 17/700242
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8243
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700242 | Anti-VLA-4 related assays | Mar 20, 2022 | Issued |
Array
(
[id] => 20358345
[patent_doc_number] => 12474336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Biomarkers for predicting multiple sclerosis disease activity
[patent_app_type] => utility
[patent_app_number] => 17/687322
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 40681
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687322 | Biomarkers for predicting multiple sclerosis disease activity | Mar 3, 2022 | Issued |
Array
(
[id] => 19158995
[patent_doc_number] => 20240151702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => METHODS OF MAKING AND ASSESSING ALLERGENIC TREE NUT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/548674
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548674 | METHODS OF MAKING AND ASSESSING ALLERGENIC TREE NUT COMPOSITIONS | Mar 3, 2022 | Pending |
Array
(
[id] => 19433886
[patent_doc_number] => 20240302384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA
[patent_app_type] => utility
[patent_app_number] => 18/547759
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547759 | METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA | Mar 2, 2022 | Pending |
Array
(
[id] => 18924437
[patent_doc_number] => 20240027441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => DEVICES AND METHODS FOR PERFORMING LATERAL FLOW TESTS
[patent_app_type] => utility
[patent_app_number] => 18/548745
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548745 | DEVICES AND METHODS FOR PERFORMING LATERAL FLOW TESTS | Mar 1, 2022 | Pending |
Array
(
[id] => 17673120
[patent_doc_number] => 20220186287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE
[patent_app_type] => utility
[patent_app_number] => 17/683939
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683939 | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence | Feb 28, 2022 | Issued |
Array
(
[id] => 19573118
[patent_doc_number] => 20240377410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C
[patent_app_type] => utility
[patent_app_number] => 18/548043
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548043
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548043 | METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C | Feb 28, 2022 | Pending |
Array
(
[id] => 17642376
[patent_doc_number] => 20220170114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/673329
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673329 | BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF | Feb 15, 2022 | Abandoned |
Array
(
[id] => 19419422
[patent_doc_number] => 20240295545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => GLIOMA THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/276956
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276956
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276956 | GLIOMA THERAPY | Feb 10, 2022 | Pending |
Array
(
[id] => 20116882
[patent_doc_number] => 12366582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Collagen type X alpha-1 assay
[patent_app_type] => utility
[patent_app_number] => 17/584517
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 2509
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584517 | Collagen type X alpha-1 assay | Jan 25, 2022 | Issued |
Array
(
[id] => 20337397
[patent_doc_number] => 20250341517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => SWITCHING PEPTIDE, IMMUNOASSAY DEVICE COMPRISING SAME, AND IMMUNOASSAY METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/259686
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259686 | SWITCHING PEPTIDE, IMMUNOASSAY DEVICE COMPRISING SAME, AND IMMUNOASSAY METHOD USING SAME | Jan 13, 2022 | Pending |
Array
(
[id] => 17580213
[patent_doc_number] => 20220137068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => S100A8 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/575176
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575176 | S100A8 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Jan 12, 2022 | Pending |
Array
(
[id] => 17564418
[patent_doc_number] => 20220128567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/573123
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573123 | Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment | Jan 10, 2022 | Issued |
Array
(
[id] => 19052218
[patent_doc_number] => 20240094187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES
[patent_app_type] => utility
[patent_app_number] => 18/259727
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259727
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259727 | SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES | Dec 28, 2021 | Pending |
Array
(
[id] => 18989024
[patent_doc_number] => 20240060993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => METHOD BY WHICH BIOSENSOR DEVICE DETECTS ANTIGEN BY USING MULTIPLE FREQUENCIES
[patent_app_type] => utility
[patent_app_number] => 18/270156
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270156 | METHOD BY WHICH BIOSENSOR DEVICE DETECTS ANTIGEN BY USING MULTIPLE FREQUENCIES | Dec 27, 2021 | Pending |
Array
(
[id] => 17521470
[patent_doc_number] => 20220107319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => SYSTEMS AND METHODS FOR THE MOLECULAR QUANTIFICATION OF SKIN DAMAGE IN SKIN
[patent_app_type] => utility
[patent_app_number] => 17/551112
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551112 | SYSTEMS AND METHODS FOR THE MOLECULAR QUANTIFICATION OF SKIN DAMAGE IN SKIN | Dec 13, 2021 | Abandoned |